Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [13090]

Novel immunotherapy demonstrates early potential to overcome resistance to immune checkpoint therapy

Novel immunotherapy demonstrates early potential to overcome resistance to immune checkpoint therapy

Therapies that target specific type of cell death may be an effective avenue for cancer treatment

Therapies that target specific type of cell death may be an effective avenue for cancer treatment

Researchers help create largest immune cell atlas of bone marrow in multiple myeloma patients

Researchers help create largest immune cell atlas of bone marrow in multiple myeloma patients

Study: ADRIATIC clinical trial results suggest durvalumab may offer a new path in small cell lung cancer care

Study: ADRIATIC clinical trial results suggest durvalumab may offer a new path in small cell lung cancer care

Inflammatory immune cells predict survival, relapse in multiple myeloma

Inflammatory immune cells predict survival, relapse in multiple myeloma

Researchers uncover how tumours become resistant to promising p53-targeted therapy

Researchers uncover how tumours become resistant to promising p53-targeted therapy

Benefit of nivolumab combo in teens with advanced Hodgkin lymphoma confirmed

Benefit of nivolumab combo in teens with advanced Hodgkin lymphoma confirmed

Patients with clonal haematopoiesis have increased heart disease risk following cancer treatment

Patients with clonal haematopoiesis have increased heart disease risk following cancer treatment

Particles supercharge cancer immunotherapy

Particles supercharge cancer immunotherapy

Researchers develop treatment for advanced prostate cancer that could eliminate severe side effects

Researchers develop treatment for advanced prostate cancer that could eliminate severe side effects

More from ecancer